Reporting by STAT’s Lizzy Lawrence reveals growing instability and political influence inside the FDA, where traditional scientific independence is weakening. Internal sources describe an agency increasingly driven by political priorities rather than evidence, including accelerated drug reviews tied to policy goals and White House involvement in regulatory decisions. Her reporting also highlights shifts in vaccine oversight, with tighter standards and internal efforts that could restrict or complicate future vaccine approvals.
